|
The adjuvant combination PVP-AF04 enhances the antibody response towards SARS-CoV antigens
The adjuvant combination PVP-AF04 enhances the antibody response towards SARS-CoV antigens
Background
As of 2024, SARS-CoV-2 has caused over 1 million deaths in the United States and more than 7 million worldwide. As the virus continues to mutate, it is important to advance immunization efforts to combat the virus’s effects, especially...
Published: 3/24/2026
|
Updated: 5/8/2024
|
Inventor(s): Ofer Levy, Yoshine Saito, Francesco Borriello, David Dowling, Timothy Yu
Keywords(s):
Category(s): Technology Classifications > Disease Area > Infectious Disease, Technology Classifications > Disease Area > Infectious Disease > COVID-19, Technology Classifications > Invention Type > Vaccines > Adjuvants
|
|
SARS-COV-2 Antigen Nanoparticles and Uses Thereof
SARS-COV-2 Antigen Nanoparticles and Uses Thereof
Background
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), a novel betacoronavirus, has caused a global health crisis and still poses a substantial risk to public health, leading to over 103 million reported infections in the United States and over 774 million worldwide since 2019. The...
Published: 3/24/2026
|
Updated: 2/13/2024
|
Inventor(s): Ofer Levy, Francesco Boriello, David Dowling, Sirano Dhe-Pagnon, Hyuk-Su Seo, David Scott, Frederic Feru
Keywords(s):
Category(s): Technology Classifications > Disease Area > Immunology, Technology Classifications > Disease Area > Infectious Disease, Technology Classifications > Disease Area > Infectious Disease > COVID-19, Technology Classifications > Invention Type > Vaccines, Technology Classifications > Invention Type > Vaccines > Adjuvants
|
|
Lipid Gb3 as an adjuvant for anti-viral vaccination
Lipid Gb3 as adjuvant for anti-viral vaccination
Background
Adjuvants are vaccine components added to enhance the magnitude, breadth, and durability of response.
Selection of appropriate adjuvants requires improved understanding of immune responses to pathogens/antigens by B cells (white blood cells). B cells develop in the bone marrow and are...
Published: 3/23/2026
|
Updated: 1/12/2024
|
Inventor(s): Florian Winau, Pankaj Sharma
Keywords(s): Adjuvants, Immunology
Category(s): Technology Classifications > Disease Area > Immunology, Technology Classifications > Disease Area > Infectious Disease, Technology Classifications > Invention Type > Vaccines > Adjuvants
|
